Following the Food and Drug Administration’s recent decision to give the green light to aducanumab, the first treatment approved for Alzheimer’s disease in nearly two decades, the agency has been ...
Calaneet Balas, executive vice president for strategy since joining the charity in 2016, has been promoted to president and chief executive officer. She previously served as CEO of the Ovarian Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results